<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04773457</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00037804</org_study_id>
    <nct_id>NCT04773457</nct_id>
  </id_info>
  <brief_title>Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients</brief_title>
  <official_title>Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical site infections (SSIs) are one of the major hospital acquired infections and&#xD;
      responsible for the most cost among the hospital acquired infections. The objective of this&#xD;
      study is to assess the neutrophil functional profiles and their associations with SSIs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2022</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neutrophil populations</measure>
    <time_frame>up to 3 days</time_frame>
    <description>compare neutrophil population between patients with SSI and without SSI by delineating transcriptomic profiles</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neutrophil functional impairment</measure>
    <time_frame>up to 3 days</time_frame>
    <description>illustrate neutrophil subpopulation associated with neutrophil functional impairment and SSIs by probing phagocytosis and reactive oxygen species formation</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Spine Surgery</arm_group_label>
    <description>Pediatric patients presenting for elective spine fusion surgery at Boston Children's Hospital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdominal Surgery</arm_group_label>
    <description>Pediatric patients presenting for elective abdominal surgery at Boston Children's Hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Surgical Site Infection</intervention_name>
    <description>infection at the site of the surgery (spine or abdomen)</description>
    <arm_group_label>Abdominal Surgery</arm_group_label>
    <arm_group_label>Spine Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients presenting for elective surgical procedures (open gastrointestinal&#xD;
        surgery or spine fusion surgery) at Boston Children's Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  scheduled for an elective open gastrointestinal surgical procedure or spine fusion&#xD;
             surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  On chronic immunosuppressive drugs such as chronic corticosteroid use&#xD;
&#xD;
          -  preexisting immunodeficiency diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Koichi Yuki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Koichi Yuki, MD</last_name>
    <phone>617-355-6225</phone>
    <email>koichi.yuki@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Bernier, MPH</last_name>
    <phone>857-218-5348</phone>
    <email>rachel.bernier@childrens.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Children's Hopsital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Koichi Yuki, MD</last_name>
      <phone>617-355-6225</phone>
      <email>koichi.yuki@childrens.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Koichi Yuki</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

